{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:07:17Z","timestamp":1783040837336,"version":"3.54.6"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32270758"],"award-info":[{"award-number":["32270758"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32070779"],"award-info":[{"award-number":["32070779"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31770811"],"award-info":[{"award-number":["31770811"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.phymed.2025.157749","type":"journal-article","created":{"date-parts":[[2025,12,28]],"date-time":"2025-12-28T15:05:56Z","timestamp":1766934356000},"page":"157749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A chalcone-rich extract from licorice root inhibits liver steatosis and fibrosis via regulating PPAR\u03b1 and TGF\u03b2 signaling"],"prefix":"10.1016","volume":"151","author":[{"given":"Ying","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4299-6622","authenticated-orcid":false,"given":"Baibo","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.phymed.2025.157749_bib0001","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","article-title":"Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases","volume":"66","author":"Adams","year":"2017","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0002","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.2040-4603.2018.tb00008.x","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr. Physiol"},{"issue":"5","key":"10.1016\/j.phymed.2025.157749_bib0003","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"issue":"3","key":"10.1016\/j.phymed.2025.157749_bib0004","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov"},{"issue":"3","key":"10.1016\/j.phymed.2025.157749_bib0005","doi-asserted-by":"crossref","first-page":"326","DOI":"10.4093\/dmj.2020.0272","article-title":"Lobeglitazone: a novel thiazolidinedione for the management of type 2 diabetes mellitus","volume":"45","author":"Bae","year":"2021","journal-title":"Diabetes Metab J"},{"issue":"9","key":"10.1016\/j.phymed.2025.157749_bib0006","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","article-title":"Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia","volume":"19","author":"Bor\u00e9n","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.phymed.2025.157749_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0199166","article-title":"Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"13","author":"Chang","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phymed.2025.157749_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/nu9020096","article-title":"Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD)","volume":"9","author":"Chen","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.phymed.2025.157749_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154338","article-title":"The role of peroxisome proliferator-activated receptors (PPAR) in immune responses","volume":"114","author":"Christofides","year":"2021","journal-title":"Metab. Clin. Exp"},{"issue":"6958","key":"10.1016\/j.phymed.2025.157749_bib0010","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-\u03b2 family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.phymed.2025.157749_bib0011","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111419","article-title":"TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019","volume":"8","author":"Dewidar","year":"2019","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.phymed.2025.157749_bib0012","doi-asserted-by":"crossref","first-page":"852","DOI":"10.7150\/ijbs.19370","article-title":"Emerging roles of SIRT1 in fatty liver diseases","volume":"13","author":"Ding","year":"2017","journal-title":"Int. J. Biol. Sci"},{"issue":"2","key":"10.1016\/j.phymed.2025.157749_bib0013","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"6","key":"10.1016\/j.phymed.2025.157749_bib0014","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jhep.2011.02.035","article-title":"DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH","volume":"55","author":"G\u00e4bele","year":"2011","journal-title":"J. Hepatol"},{"issue":"4","key":"10.1016\/j.phymed.2025.157749_bib0015","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.31843","article-title":"Saroglitazar, a PPAR-\u03b1\/\u03b3 agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial","volume":"74","author":"Gawrieh","year":"2021","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0016","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol"},{"issue":"9","key":"10.1016\/j.phymed.2025.157749_bib0017","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092555","article-title":"Flavonones from ameliorate hepatic steatosis by activating the SIRT1\/AMPK pathway in HepG2 cells","volume":"19","author":"Guo","year":"2018","journal-title":"Int. J. Mol. Sci"},{"issue":"24","key":"10.1016\/j.phymed.2025.157749_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415489","article-title":"Non-alcoholic fatty liver disease (NAFLD) pathogenesis and natural products for prevention and treatment","volume":"23","author":"Guo","year":"2022","journal-title":"Int. J. Mol. Sci"},{"key":"10.1016\/j.phymed.2025.157749_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101833","article-title":"Emerging role of aging in the progression of NAFLD to HCC","volume":"84","author":"He","year":"2023","journal-title":"Ageing Res. Rev"},{"key":"10.1016\/j.phymed.2025.157749_bib0020","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","author":"Hernandez-Gea","year":"2011","journal-title":"Annu. Rev. Pathol"},{"key":"10.1016\/j.phymed.2025.157749_bib0021","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev"},{"key":"10.1016\/j.phymed.2025.157749_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153412","article-title":"Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe mice: role of SIRT1","volume":"81","author":"Hua","year":"2021","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.phymed.2025.157749_bib0023","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","article-title":"Immune cell-mediated features of non-alcoholic steatohepatitis","volume":"22","author":"Huby","year":"2021","journal-title":"Nat. Rev. Immunol"},{"issue":"8","key":"10.1016\/j.phymed.2025.157749_bib0024","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1113\/JP281061","article-title":"Hepatic stellate cells in physiology and pathology","volume":"600","author":"Kamm","year":"2022","journal-title":"J. Physiol"},{"issue":"6785","key":"10.1016\/j.phymed.2025.157749_bib0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/35013000","article-title":"Roles of PPARs in health and disease","volume":"405","author":"Kersten","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2025.157749_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.770986","article-title":"Endotoxins and non-alcoholic fatty liver disease","volume":"12","author":"Kessoku","year":"2021","journal-title":"Front. Endocrinol"},{"issue":"3","key":"10.1016\/j.phymed.2025.157749_bib0027","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0028","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1089\/jmf.2019.4459","article-title":"A review of the pharmacological efficacy and safety of licorice root from corroborative clinical trial findings","volume":"23","author":"Kwon","year":"2020","journal-title":"J. Med. Food"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0029","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12929-016-0309-5","article-title":"PPARs modulate cardiac metabolism and mitochondrial function in diabetes","volume":"24","author":"Lee","year":"2017","journal-title":"J. Biomed. Sci"},{"key":"10.1016\/j.phymed.2025.157749_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102745","article-title":"\u03b2-nicotinamide mononucleotide activates NAD+\/SIRT1 pathway and attenuates inflammatory and oxidative responses in the hippocampus regions of septic mice","volume":"63","author":"Li","year":"2023","journal-title":"Redox Biol"},{"issue":"10","key":"10.1016\/j.phymed.2025.157749_bib0031","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1055\/a-2266-1503","article-title":"The pathophysiological associations between obesity, NAFLD, and atherosclerotic cardiovascular diseases","volume":"56","author":"Li","year":"2024","journal-title":"Horm. Metab. Res"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0032","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12943-024-02213-6","article-title":"Tailoring traditional Chinese medicine in cancer therapy","volume":"24","author":"Li","year":"2025","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.phymed.2025.157749_bib0033","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clnu.2023.12.005","article-title":"Peroxisome proliferator-activated receptors: a key link between lipid metabolism and cancer progression","volume":"43","author":"Li","year":"2024","journal-title":"Clin. Nutr"},{"issue":"6","key":"10.1016\/j.phymed.2025.157749_bib0034","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/hep.30986","article-title":"qFIBS: an automated technique for quantitative evaluation of fibrosis, inflammation, ballooning, and steatosis in patients with nonalcoholic steatohepatitis","volume":"71","author":"Liu","year":"2020","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.phymed.2025.157749_bib0035","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/acs.jnatprod.2c00990","article-title":"Dihydrotrichodimerol purified from the marine FungusAcremonium citrinumPrevents NAFLD by targeting ppar\u03b1","volume":"86","author":"Liu","year":"2023","journal-title":"J. Nat. Prod"},{"issue":"10","key":"10.1016\/j.phymed.2025.157749_bib0036","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.phymed.2025.157749_bib0037","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol"},{"key":"10.1016\/j.phymed.2025.157749_bib0038","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejmech.2019.01.067","article-title":"Role of PPAR receptor in different diseases and their ligands: physiological importance and clinical implications","volume":"166","author":"Mirza","year":"2019","journal-title":"Eur. J. Med. Chem"},{"issue":"7","key":"10.1016\/j.phymed.2025.157749_bib0039","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1136\/gutjnl-2015-310798","article-title":"Liver ppar\u03b1 is crucial for whole-body fatty acid homeostasis and is protective against NAFLD","volume":"65","author":"Montagner","year":"2016","journal-title":"Gut"},{"issue":"13","key":"10.1016\/j.phymed.2025.157749_bib0040","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1038\/onc.2012.191","article-title":"Genome-wide mechanisms of Smad binding","volume":"32","author":"Morikawa","year":"2013","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","article-title":"Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD)","volume":"48","author":"Musso","year":"2009","journal-title":"Prog. Lipid Res"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0042","article-title":"Kupffer cell metabolism and function","volume":"1","author":"Nguyen-Lefebvre","year":"2015","journal-title":"J. enzymol. metab."},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0043","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1038\/s41467-021-23048-5","article-title":"Interplay between transforming growth factor-\u03b2 and Nur77 in dual regulations of inhibitor of differentiation 1 for colonic tumorigenesis","volume":"12","author":"Niu","year":"2021","journal-title":"Nat. Commun"},{"key":"10.1016\/j.phymed.2025.157749_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101231","article-title":"Liver fibrosis in NAFLD\/NASH: from pathophysiology towards diagnostic and therapeutic strategies","volume":"95","author":"Parola","year":"2024","journal-title":"Mol. Asp. Med"},{"issue":"6","key":"10.1016\/j.phymed.2025.157749_bib0045","article-title":"Lipid alterations in chronic liver disease and liver cancer","volume":"4","author":"Paul","year":"2022","journal-title":"Jhep Rep."},{"issue":"3","key":"10.1016\/j.phymed.2025.157749_bib0046","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of ppar\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol"},{"issue":"10290","key":"10.1016\/j.phymed.2025.157749_bib0047","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.phymed.2025.157749_bib0048","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI27300","article-title":"Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2","volume":"116","author":"Savage","year":"2006","journal-title":"J. Clin. Invest"},{"issue":"3","key":"10.1016\/j.phymed.2025.157749_bib0049","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/07853890.2010.547211","article-title":"Sirtuin 1 in lipid metabolism and obesity","volume":"43","author":"Schug","year":"2011","journal-title":"Ann. Med"},{"key":"10.1016\/j.phymed.2025.157749_bib0050","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.matbio.2018.04.006","article-title":"Liver fibrosis: direct antifibrotic agents and targeted therapies","volume":"68-69","author":"Schuppan","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.phymed.2025.157749_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2023.105452","article-title":"Revisiting Licorice as a functional food in the management of neurological disorders: bench to trend","volume":"155","author":"Sharma","year":"2023","journal-title":"Neurosci. Biobehav. Rev"},{"issue":"4","key":"10.1016\/j.phymed.2025.157749_bib0052","doi-asserted-by":"crossref","first-page":"E730","DOI":"10.1152\/ajpendo.00225.2016","article-title":"Treatment of nonalcoholic fatty liver disease: role of AMPK","volume":"311","author":"Smith","year":"2016","journal-title":"Am. J. Physiol.-Endocrinol. Metab"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0053","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4161\/15548627.2014.984271","article-title":"Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway","volume":"11","author":"Song","year":"2015","journal-title":"Autophagy"},{"issue":"6","key":"10.1016\/j.phymed.2025.157749_bib0054","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/j.jhep.2017.02.026","article-title":"Targeting hepatic macrophages to treat liver diseases","volume":"66","author":"Tacke","year":"2017","journal-title":"J. Hepatol"},{"key":"10.1016\/j.phymed.2025.157749_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.730176","article-title":"Liver fibrosis: therapeutic targets and advances in drug therapy","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Cell Dev. Biol"},{"issue":"2","key":"10.1016\/j.phymed.2025.157749_bib0056","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.101215","article-title":"NAFLD, and cardiovascular and cardiac diseases: factors influencing risk, prediction and treatment","volume":"47","author":"Targher","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.phymed.2025.157749_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107155","article-title":"SIRT1: harnessing multiple pathways to hinder NAFLD","volume":"203","author":"Tian","year":"2024","journal-title":"Pharmacol. Res"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0058","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13020-023-00729-5","article-title":"Honokiol acts as an AMPK complex agonist therapeutic in non-alcoholic fatty liver disease and metabolic syndrome","volume":"18","author":"Tian","year":"2023","journal-title":"Chin Med"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0059","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","article-title":"PPAR agonists for the treatment of neuroinflammatory diseases","volume":"45","author":"Titus","year":"2024","journal-title":"Trends Pharmacol. Sci"},{"key":"10.1016\/j.phymed.2025.157749_bib0060","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1146\/annurev.biochem.77.061307.091829","article-title":"Fat and beyond:: the diverse biology of PPAR\u03b3","volume":"77","author":"Tontonoz","year":"2008","journal-title":"Annu. Rev. Biochem"},{"issue":"7","key":"10.1016\/j.phymed.2025.157749_bib0061","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0062","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-33070-1","article-title":"FXR agonist obeticholic acid induces liver growth but exacerbates biliary injury in rats with obstructive cholestasis","volume":"8","author":"van Golen","year":"2018","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.phymed.2025.157749_bib0063","article-title":"(Licorice): a comprehensive review on its phytochemistry, biological activities, clinical evidence and toxicology","volume":"10","author":"Wahab","year":"2021","journal-title":"Plants-Basel"},{"issue":"8","key":"10.1016\/j.phymed.2025.157749_bib0064","doi-asserted-by":"crossref","first-page":"e3018","DOI":"10.1038\/cddis.2017.410","article-title":"Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1\/LKB1\/AMPK pathway","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.phymed.2025.157749_bib0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1207\/S15327914nc391_1","article-title":"Licorice and cancer","volume":"39","author":"Wang","year":"2001","journal-title":"Nutr. Cancer"},{"issue":"11","key":"10.1016\/j.phymed.2025.157749_bib0066","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202003721","article-title":"Adipocyte fatty acid binding protein promotes the onset and progression of liver fibrosis via mediating the crosstalk between liver sinusoidal endothelial cells and hepatic stellate cells","volume":"8","author":"Wu","year":"2021","journal-title":"Adv. Sci"},{"issue":"4","key":"10.1016\/j.phymed.2025.157749_bib0067","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7150\/ijbs.39936","article-title":"Compound C enhances the anticancer effect of aspirin in HER-2-positive breast cancer by regulating lipid metabolism in an AMPK-independent pathway","volume":"16","author":"Wu","year":"2020","journal-title":"Int. J. Biol. Sci"},{"issue":"3","key":"10.1016\/j.phymed.2025.157749_bib0068","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1369\/0022155415627681","article-title":"TGF-\u03b2\/SMAD pathway and its regulation in hepatic fibrosis","volume":"64","author":"Xu","year":"2016","journal-title":"J. Histochem. Cytochem"},{"issue":"5","key":"10.1016\/j.phymed.2025.157749_bib0069","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13050626","article-title":"Novel selective ppar\u03b1 modulator pemafibrate for dyslipidemia, nonalcoholic fatty liver disease (NAFLD), and atherosclerosis","volume":"13","author":"Yamashita","year":"2023","journal-title":"Metabolites"},{"issue":"8","key":"10.1016\/j.phymed.2025.157749_bib0070","doi-asserted-by":"crossref","DOI":"10.3390\/biom12081079","article-title":"Progress in nonalcoholic fatty liver disease: SIRT Family regulates mitochondrial biogenesis","volume":"12","author":"Zeng","year":"2022","journal-title":"Biomolecules"},{"issue":"8","key":"10.1016\/j.phymed.2025.157749_bib0071","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1042\/CS20150623","article-title":"Fenofibrate increases cardiac autophagy via FGF21\/SIRT1 and prevents fibrosis and inflammation in the hearts of type 1 diabetic mice","volume":"130","author":"Zhang","year":"2016","journal-title":"Clin. Sci"},{"issue":"23","key":"10.1016\/j.phymed.2025.157749_bib0072","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.3748\/wjg.v21.i23.7155","article-title":"Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats","volume":"21","author":"Zhen","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.phymed.2025.157749_bib0073","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/cmi.2015.97","article-title":"Hepatocytes: a key cell type for innate immunity","volume":"13","author":"Zhou","year":"2016","journal-title":"Cell. Mol. Immunol"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325013832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711325013832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:55:32Z","timestamp":1773968132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711325013832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":73,"alternative-id":["S0944711325013832"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157749","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A chalcone-rich extract from licorice root inhibits liver steatosis and fibrosis via regulating PPAR\u03b1 and TGF\u03b2 signaling","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2025.157749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"157749"}}